Terms: = Endocrine gland cancer AND TPM3, ENSG00000143549, 7170
19 results:
1. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic cancer.
Zou T; Shi D; Wang W; Chen G; Zhang X; Tian Y; Gong P
Mediators Inflamm; 2023; 2023():5565054. PubMed ID: 37181810
[TBL] [Abstract] [Full Text] [Related]
2. Incidence and risk factors of cardiovascular mortality in patients with gastrointestinal adenocarcinoma.
Nso N; Nyabera A; Nassar M; Mbome Y; Emmanuel K; Alshamam M; Sumbly V; Guzman L; Shaukat T; Bhangal R; Ojong GA; Radparvar F; Rizzo V; Munira MS
PLoS One; 2023; 18(1):e0262013. PubMed ID: 36706093
[TBL] [Abstract] [Full Text] [Related]
3. Facility type and size-stratified analysis of management patterns and outcomes of patients with localized non-functional pancreatic neuroendocrine tumors.
Hue JJ; Sugumar K; Ammori JB; Rothermel LD; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2022 Apr; 24(4):498-506. PubMed ID: 34419354
[TBL] [Abstract] [Full Text] [Related]
4. Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents.
Xu X; Wang Y; Bryce NS; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW
Br J Cancer; 2021 Jul; 125(2):265-276. PubMed ID: 33981016
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian cancer: A Systematic Review and Meta-analysis.
Paoletti X; Lewsley LA; Daniele G; Cook A; Yanaihara N; Tinker A; Kristensen G; Ottevanger PB; Aravantinos G; Miller A; Boere IA; Fruscio R; Reyners AKL; Pujade-Lauraine E; Harkin A; Pignata S; Kagimura T; Welch S; Paul J; Karamouza E; Glasspool RM;
JAMA Netw Open; 2020 Jan; 3(1):e1918939. PubMed ID: 31922558
[TBL] [Abstract] [Full Text] [Related]
7. Whole solid tumour volume histogram analysis of the apparent diffusion coefficient for differentiating high-grade from low-grade serous ovarian carcinoma: correlation with Ki-67 proliferation status.
Li HM; Zhang R; Gu WY; Zhao SH; Lu N; Zhang GF; Peng WJ; Qiang JW
Clin Radiol; 2019 Dec; 74(12):918-925. PubMed ID: 31471063
[TBL] [Abstract] [Full Text] [Related]
8. Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma.
van der Tuin K; Ventayol Garcia M; Corver WE; Khalifa MN; Ruano Neto D; Corssmit EPM; Hes FJ; Links TP; Smit JWA; Plantinga TS; Kapiteijn E; van Wezel T; Morreau H
Eur J Endocrinol; 2019 Apr; 180(4):235-241. PubMed ID: 30668525
[TBL] [Abstract] [Full Text] [Related]
9. Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.
Ronsley R; Rassekh SR; Shen Y; Lee AF; Jantzen C; Halparin J; Albert C; Hawkins DS; Amed S; Rothstein R; Mungall AJ; Dix D; Blair G; Nadel H; Jones SJM; Laskin J; Marra MA; J Deyell R
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610391
[TBL] [Abstract] [Full Text] [Related]
10. Surgical treatment of 21 patients with spinal metastases of differentiated thyroid cancer.
Jiang L; Ouyang H; Liu X; Wei F; Wu F; Dang L; Liu Z
Chin Med J (Engl); 2014; 127(23):4092-6. PubMed ID: 25430455
[TBL] [Abstract] [Full Text] [Related]
11. Anchored multiplex PCR for targeted next-generation sequencing.
Zheng Z; Liebers M; Zhelyazkova B; Cao Y; Panditi D; Lynch KD; Chen J; Robinson HE; Shim HS; Chmielecki J; Pao W; Engelman JA; Iafrate AJ; Le LP
Nat Med; 2014 Dec; 20(12):1479-84. PubMed ID: 25384085
[TBL] [Abstract] [Full Text] [Related]
12. Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.
Tang HY; Beer LA; Tanyi JL; Zhang R; Liu Q; Speicher DW
J Proteomics; 2013 Aug; 89():165-78. PubMed ID: 23792823
[TBL] [Abstract] [Full Text] [Related]
13. Histotype-specific copy-number alterations in ovarian cancer.
Huang RY; Chen GB; Matsumura N; Lai HC; Mori S; Li J; Wong MK; Konishi I; Thiery JP; Goh L
BMC Med Genomics; 2012 Oct; 5():47. PubMed ID: 23078675
[TBL] [Abstract] [Full Text] [Related]
14. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
Greco A; Miranda C; Pierotti MA
Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
[TBL] [Abstract] [Full Text] [Related]
15. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
Brzeziańska E; Karbownik M; Migdalska-Sek M; Pastuszak-Lewandoska D; Włoch J; Lewiński A
Mutat Res; 2006 Jul; 599(1-2):26-35. PubMed ID: 16483615
[TBL] [Abstract] [Full Text] [Related]
16. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract] [Full Text] [Related]
17. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.
Beimfohr C; Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Int J Cancer; 1999 Mar; 80(6):842-7. PubMed ID: 10074915
[TBL] [Abstract] [Full Text] [Related]
18. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
[TBL] [Abstract] [Full Text] [Related]
19. A sequence analysis of the genomic regions involved in the rearrangements between tpm3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
[TBL] [Abstract] [Full Text] [Related]
